Cancer Research AACR Conference on Molecular Diagnostics - 2008  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 1597-1603, May 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zbar, B.
Right arrow Articles by Ribi, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zbar, B.
Right arrow Articles by Ribi, E.

Eradication by Immunization with Mycobacterial Vaccines and Tumor Cells of Microscopic Metastases Remaining after Surgery

B. Zbar1, G. Canti2, M. P. Ashley, H. J. Rapp, J. T. Hunter and E. Ribi

Laboratory of Immunobiology, National Cancer Institute, NIH, Bethesda, Maryland 20014 [B. Z., G. C., M. P. A., H. J. R., J. T. H.], and the Rocky Mountain Laboratory, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, Montana 59840 [E. R.]

Guinea pigs, each with a growing tumor from hepatoma cells implanted in the skin, were treated either by surgical excision alone of the dermal tumor or by surgery followed by administration of emulsified Bacillus Calmette-Guérin (BCG) cell walls alone or mixed with hepatoma cells. Animals treated by surgery alone developed malignant disease characterized by progressive lethal growth of lymph node metastasis. Injections of cell walls intradermally between the site of excision and the draining lymph node (regional injection) prevented the development of palpable metastasis in some animals; cell walls given intradermally on the side contralateral to the surgical site (remote injection) cured no animals. Similar treatments with preparations containing both cell walls and hepatoma cells prevented the development of malignant disease in a significant number of animals whether the injections were regional or remote. Treatment with mixtures consisting of living BCG and tumor cells was not as effective as treatment with cell walls mixed with tumor cells. A mixture consisting of modified BCG cell walls known as skeletons, trehalose dimycolate also known as cord factor or P3, and endotoxin was an effective substitute for BCG cell walls. There was no particular advantage in the use of the mixture containing BCG cell wall skeletons, trehalose dimycolate, and endotoxin instead of BCG cell walls. Neither preparation produced any gross systemic toxicity, and there was no statistical difference in their therapeutic efficacy. Undegraded cell wall emulsions were easier and less costly to prepare than was the three-component mixture. Animals treated by surgery followed by administration of BCG cell walls together with cells from another syngeneic hepatoma, immunologically distinct from the dermally implanted tumor, failed to eradicate microscopic lymph node metastases.

1 To whom requests for reprints should be addressed.

2 Present address: Instituto di Farmacologia, Milan, Italy.

Received 9/ 5/78. Accepted 2/ 8/79.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.